查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493309

生醫材料市場規模、佔有率、趨勢分析報告：按產品、按應用、按地區、細分市場預測，2024-2030

Biomaterials Market Size, Share & Trends Analysis Report By Product (Natural, Metallic, Polymer), By Application (Cardiovascular, Orthopedics, Plastic Surgery), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 170 Pages | 商品交期: 2-10個工作天內

價格

生醫材料市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球生醫材料市場規模預計將達到4,887億美元，預測期內複合年成長率為15.6%。

生物材料的應用是生物醫學研究快速發展的領域。提高生物材料的生物活性、相容性和機械性能的最新進展為組織工程、免疫工程和藥物傳輸系統的應用提供了新的機會。

聚合生醫材料的生物相容性、低毒性和可再生使其成為受控和靶向藥物輸送中強大的藥物輸送劑，為市場成長提供了利潤豐厚的機會。改良的藥物傳遞方法的出現，例如 PEG 包覆的脂質體、生物聚合物包覆的脂質體和奈米材料藥物遞送，進一步擴大了生物聚合物在製藥和醫療產業的前景。

生物材料的使用極大地幫助了心肺系統的再生。這些材料為種子細胞提供物理支持以及生理和化學線索，有助於組織再生過程。生醫材料和奈米技術的整合也刺激受損心肌細胞的細胞外基質再生，取代傳統的器官移植。

生醫材料市場報告亮點

  • 由於天然和合成可分解聚合物的高可得性及其在手術縫合線和植入中的廣泛應用，聚合物產品部門佔據了最大的銷售佔有率。
  • 天然產物作為開發新藥的新型生物活性物質的來源而廣受歡迎，導致該領域快速成長。
  • 慢性骨骼和肌肉骨骼疾病發生率的增加預計將極大地推動對整形外科應用生醫材料的需求。
  • 可以使用基於聚合酵素鏈鎖反應（PCR）或非PCR方法的現有生物醫學設備來檢測冠狀病毒（即SARS-COV-2）的感染。
  • 改善矽膠乳房植入的表面改性以防止包膜攣縮是推動生醫材料在整形外科領域以最快速度使用的因素之一。
  • 生物感測器是用來檢測諸如組織、酵素和細胞器等微生物產生的生物分子和生物元素等分析物的分析裝置。
  • 由於有透過舉辦活動和資助計劃來促進生醫材料利用的公共和私人機構，北美預計將在收益佔有率方面佔據市場主導地位。
  • 由於多家本地製造商（主要在中國）開發低成本生醫材料產品，亞太地區預計將快速成長。
  • 市場主要企業包括Medtronic、贏創、帝斯曼、BASF、柏克萊先進生醫材料、Covalon Technologies 和 Zimmer Biomet Holdings。
  • 這些公司正在採取多項策略性成長舉措，包括新產品開發、合作夥伴關係和地理擴張，以提高其在市場上的影響力。
  • 例如，2022 年 3 月，Medtronic宣布與 Vizient 合作，將 Touchurge Enterprise 加入 Vizient 的產品組合中。該平台是一個由人工智慧驅動的視訊管理和分析平台，讓手術團隊可以輕鬆存取程式文件和見解。

目錄

第1章調查方法和範圍

第2章生醫材料市場：執行摘要

  • 市場概述
  • 段簡介
  • 競爭格局概覽

第3章生醫材料市場變數、趨勢與範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 生醫材料市場分析工具
    • 產業分析-波特五力分析
    • PESTLE分析

第4章生醫材料市場：產品估算與趨勢分析

  • 細分儀表板
  • 按產品分類的全球生醫材料市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 金屬
  • 自然的
  • 陶瓷製品
  • 聚合物

第5章生醫材料市場：應用估算/趨勢分析

  • 細分儀表板
  • 全球生醫材料應用市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 心血管
  • 眼科
  • 整形外科
  • 創傷治療
  • 組織工程
  • 整容手術
  • 神經
  • 其他

第6章生醫材料市場：區域業務分析

  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模及預測趨勢分析：
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第7章生醫材料市場：競爭格局

  • 參與企業
  • 策略規劃
  • 2023 年企業市場分析
  • 參與企業概況
  • Medtronic
  • Evonik Industries AG
  • Carpenter Technology Corporation
  • Berkeley Advanced Biomaterials
  • Invibio Ltd
  • Zimmer Biomet Holdings, Inc
  • BASF SE
  • Covalon Technologies Ltd
  • Stryker
  • Johnson & Johnson
  • Dentsply Sirona
  • CoorsTek Inc
  • Corbion
  • Regenity Biosciences
Product Code: GVR-2-68038-637-0

Biomaterials Market Growth & Trends:

The global biomaterials market size is expected to reach USD 488.70 billion by 2030, registering a CAGR of 15.6% over the forecast period, according to a new report by Grand View Research, Inc. The application of biomaterials represents a fast-growing field in biomedical research. Recent advances in the improvement of bioactivity, compatibility, and mechanical properties of biomaterials have introduced new opportunities for their application in tissue engineering, immune engineering, and drug delivery systems.

Biocompatibility, low toxicity, and renewable nature of polymeric biomaterials make them potent drug delivery agents in controlled and targeted drug delivery, thus providing lucrative opportunities for the market growth. The advent of improved drug delivery approaches, such as PEG-coated liposomes, biopolymer-coated liposomes, and nanomaterials drug delivery, further expands the prospects of these biopolymers in the pharmaceutical and medical industries.

Use of biomaterials has greatly benefited the regeneration of the cardiopulmonary system. These materials provide physical support and physiological and chemical cues to seeded cells to assist the tissue regeneration process. Integration of biomaterials with nanotechnology techniques also stimulates the regeneration of damaged cardiomyocytes' extracellular matrix, thus replacing the traditional organ transplantation procedures.

Biomaterials Market Report Highlights:

  • High availability of natural and synthetic degradable polymers and their wide usage as surgical sutures and implants resulted in the largest revenue share of the polymers product segment
  • Natural products have gained immense popularity as a source of novel bioactive substance for the development of novel drugs, leading to fastest growth of this segment
  • Increasing incidence of chronic skeletal and musculoskeletal conditions is expected to raise the demand for biomaterials for orthopedics application at a large scale
  • The infection from coronavirus, that is, SARS-COV-2 can be detected using existing biomedical devices which are based on either Polymerase Chain Reaction (PCR) or Non-PCR methods
  • Improvement in the surface modification of silicone breast implants to prevent capsular contracture is one of the factors driving the biomaterial usage in the plastic surgery segment at the fastest rate
  • Biosensor, is an analytical device that is used to detect analytes such as biomolecules or biological elements of species produced by micro-organisms, that is tissues, enzymes, and organelles
  • North America is expected to dominate the market in terms of revenue share owing to the presence of public and private agencies promoting biomaterial usage by hosting events and funding initiatives
  • Asia Pacific is anticipated to grow at a rapid pace owing to the presence of several local manufacturers developing low-cost biomaterial products, mainly in China
  • Prominent players operating in the market include Medtronic, Evonik, DSM, BASF, Berkeley Advanced Biomaterials, Covalon Technologies, and Zimmer Biomet Holdings
  • Companies are engaged in several strategic growth initiatives, such as novel product developments, partnerships, and regional expansion to reinforce their market presence
  • For instance, in March 2022, Medtronic announced a collaboration with Vizient to add Touch Surgery Enterprise to Vizient's portfolio, which is an AI-powered video management and analytical platform that provides surgical teams with simple access to procedural recordings and insights

Table of Contents

Chapter 1. Methodology And Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Segment
      • 1.1.1.2. Application Segment
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Objectives
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information Or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List Of Primary Sources
  • 1.11. List Of Abbreviations

Chapter 2. Biomaterials Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshots
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Biomaterials Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Rising Demand As A Consequence Of Accidental Injuries & Chronic Conditions
      • 3.3.1.2. Advances In Biomaterials Technologies
      • 3.3.1.3. Expansion In The Usage Scope Of Biomaterials
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. High Expense Associated With The Development Of Biomaterials
      • 3.3.2.2. Problems Related To Biocompatibility Of Biomaterials
  • 3.4. Biomaterials Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
    • 3.4.2. PESTLE Analysis

Chapter 4. Biomaterials Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Biomaterials Market By Product Outlook
  • 4.3. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 4.3.1. Metallic
      • 4.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.3.2. Natural
      • 4.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.3.3. Ceramics
      • 4.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 4.3.4. Polymers
      • 4.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 5. Biomaterials Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Biomaterials Market By Application Outlook
  • 5.3. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
    • 5.3.1. Cardiovascular
      • 5.3.1.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.2. Sensors
      • 5.3.1.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.3. Stents
      • 5.3.1.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.4. Guidewires
      • 5.3.1.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.5. Implantable Cardiac Defibrillators
      • 5.3.1.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.6. Pacemakers
      • 5.3.1.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.7. Vascular Grafts
      • 5.3.1.7.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.1.8. Others
      • 5.3.1.8.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.2. Ophthalmology
      • 5.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.2.2. Synthetic Corneas
      • 5.3.2.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.2.3. Intraocular Lens
      • 5.3.2.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.2.4. Contact Lens
      • 5.3.2.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.2.5. Ocular Tissue Replacement
      • 5.3.2.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.2.6. Others
      • 5.3.2.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.3. Dental
      • 5.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.3.2. Tissue Regeneration Materials
      • 5.3.3.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.3.3. Dental Implants
      • 5.3.3.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.3.4. Bone Grafts & Substitutes
      • 5.3.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.3.5. Dental Membranes
      • 5.3.3.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.3.6. Others
      • 5.3.3.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.4. Orthopedic
      • 5.3.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.2. Joint Replacement biomaterials
      • 5.3.4.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.3. Orthobiologics
      • 5.3.4.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.4. Bioresorbable Tissue Fixation Products
      • 5.3.4.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.5. Visco supplementation
      • 5.3.4.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.6. Spine Biomaterial
      • 5.3.4.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.4.7. Others
      • 5.3.4.7.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.5. Wound Healing
      • 5.3.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.2. Fracture Healing Device
      • 5.3.5.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.3. Adhesion Barrier
      • 5.3.5.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.4. Skin Substitutes
      • 5.3.5.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.5. Internal Tissue Sealant
      • 5.3.5.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.6. Surgical Hemostats
      • 5.3.5.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.5.7. Others
      • 5.3.5.7.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.6. Tissue Engineering
      • 5.3.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.7. Plastic Surgery
      • 5.3.7.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.2. Facial Wrinkle Treatment
      • 5.3.7.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.3. Soft Tissue Fillers
      • 5.3.7.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.4. Craniofacial Surgery
      • 5.3.7.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.5. Bioengineered Skins
      • 5.3.7.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.6. Peripheral Nerve Repair
      • 5.3.7.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.7. Acellular Dermal Matrices
      • 5.3.7.7.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.7.8. Others
      • 5.3.7.8.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.8. Neurology
      • 5.3.8.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.8.2. Neural Stem Cell Encapsulation
      • 5.3.8.2.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.8.3. Shunting Systems
      • 5.3.8.3.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.8.4. Hydrogel Scaffold For CNS Repair
      • 5.3.8.4.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.8.5. Cortical Neural Prosthetics
      • 5.3.8.5.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
      • 5.3.8.6. Others
      • 5.3.8.6.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 5.3.9. Others
      • 5.3.9.1. Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 6. Biomaterials Market: Regional Business Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Global Regional Market Snapshot
  • 6.3. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
  • 6.4. North America
    • 6.4.1. North America Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. U.S. Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Canada Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. UK Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Germany Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.4. Spain
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Spain Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.5. France
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. France Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.6. Italy
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Italy Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Denmark Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Sweden Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Competitive Scenario
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Norway Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Japan Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. China Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. India Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. South Korea Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Thailand Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.6.7. Australia
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Australia Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Brazil Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.7.3. Mexico
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Mexico Biomaterials Market, 2018 - 2030 (USD Million)
    • 6.7.4. Argentina
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Argentina Market Estimates And Forecasts 2018 To 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Biomaterials Market, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. South Africa Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Saudi Arabia Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. UAE Market Estimates And Forecasts 2018 To 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Kuwait Market Estimates And Forecasts 2018 To 2030 (USD Million)

Chapter 7. Biomaterials Market: Competitive Landscape

  • 7.1. Participant Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2023
  • 7.4. Participant's Overview
    • 7.4.1. Medtronic
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Evonik Industries AG
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Carpenter Technology Corporation
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Berkeley Advanced Biomaterials
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Invibio Ltd
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Zimmer Biomet Holdings, Inc
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. BASF SE
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Covalon Technologies Ltd
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Stryker
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Johnson & Johnson
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives
    • 7.4.11. Dentsply Sirona
      • 7.4.11.1. Overview
      • 7.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic Initiatives
    • 7.4.12. CoorsTek Inc
      • 7.4.12.1. Overview
      • 7.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Strategic Initiatives
    • 7.4.13. Corbion
      • 7.4.13.1. Overview
      • 7.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Strategic Initiatives
    • 7.4.14. Regenity Biosciences
      • 7.4.14.1. Overview
      • 7.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Biomaterials Market, Region, 2018 - 2030 (USD Million)
  • Table 3 North America Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 North America Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 5 U.S. Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 6 U.S. Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Canada Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 8 Canada Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 9 Europe Biomaterials Market, Region, 2018 - 2030 (USD Million)
  • Table 10 Europe Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 Europe Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 12 UK Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 13 UK Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 Germany Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Germany Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 16 France Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 17 France Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 18 Italy Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 Italy Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 20 Spain Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 Spain Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 22 Sweden Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Sweden Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Norway Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 25 Norway Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 26 Denmark Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 Denmark Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific Biomaterials Market, Region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 31 Japan Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 Japan Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 China Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 34 China Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 35 India Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 36 India Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 37 Australia Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 38 Australia Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 South Korea Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 40 South Korea Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 41 Thailand Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 42 Thailand Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 43 Latin America Biomaterials Market, Region, 2018 - 2030 (USD Million)
  • Table 44 Latin America Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 45 Latin America Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 46 Brazil Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 47 Brazil Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 48 Mexico Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 49 Mexico Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 50 Argentina Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 Argentina Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 MEA Biomaterials Market, Region, 2018 - 2030 (USD Million)
  • Table 53 MEA Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 54 MEA Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 South Africa Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 South Africa Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 59 UAE Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 UAE Biomaterials Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 Kuwait Biomaterials Market, By Product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait Biomaterials Market, By Application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews In North America
  • Fig. 5 Primary Interviews In Europe
  • Fig. 6 Primary Interviews In APAC
  • Fig. 7 Primary Interviews In Latin America
  • Fig. 8 Primary Interviews In MEA
  • Fig. 9 Market Research Approaches
  • Fig. 10 Value-Chain-Based Sizing & Forecasting
  • Fig. 11 QFD Modeling For Market Share Assessment
  • Fig. 12 Market Formulation & Validation
  • Fig. 13 Biomaterials Market: Market Outlook
  • Fig. 14 Biomaterials Competitive Insights
  • Fig. 15 Parent Market Outlook
  • Fig. 16 Related/Ancillary Market Outlook
  • Fig. 17 Penetration And Growth Prospect Mapping
  • Fig. 18 Industry Value Chain Analysis
  • Fig. 19 Biomaterials Market Driver Impact
  • Fig. 20 Biomaterials Market Restraint Impact
  • Fig. 21 Biomaterials Market Strategic Initiatives Analysis
  • Fig. 22 Biomaterials Market: Product Movement Analysis
  • Fig. 23 Biomaterials Market: Product Outlook And Key Takeaways
  • Fig. 24 Logistics & distribution Market Estimates And Forecast, 2018 - 2030
  • Fig. 25 Metallic Market Estimates And Forecast, 2018 - 2030
  • Fig. 26 Natural Market Estimates And Forecast, 2018 - 2030
  • Fig. 27 Ceramics Market Estimates And Forecast, 2018 - 2030
  • Fig. 28 Polymers Market Estimates And Forecast, 2018 - 2030
  • Fig. 29 Biomaterials Market: Application Movement Analysis
  • Fig. 30 Biomaterials Market: Application Outlook And Key Takeaways
  • Fig. 31 Cardiovascular Market Estimates And Forecasts, 2018 - 2030
  • Fig. 32 Ophthalmology Market Estimates And Forecasts, 2018 - 2030
  • Fig. 33 Dental Market Estimates And Forecasts, 2018 - 2030
  • Fig. 34 Orthopedic Market Estimates And Forecasts, 2018 - 2030
  • Fig. 35 Wound Healing Market Estimates And Forecasts, 2018 - 2030
  • Fig. 36 Tissue Engineering Market Estimates And Forecasts, 2018 - 2030
  • Fig. 37 Plastic Surgery Market Estimates And Forecasts, 2018 - 2030
  • Fig. 38 Neurology Market Estimates And Forecasts, 2018 - 2030
  • Fig. 39 Others Market Estimates And Forecasts, 2018 - 2030
  • Fig. 40 Global Biomaterials Market: Regional Movement Analysis
  • Fig. 41 Global Biomaterials Market: Regional Outlook And Key Takeaways
  • Fig. 42 Global Biomaterials Market Share And Leading Players
  • Fig. 43 North America Market Share And Leading Players
  • Fig. 44 Europe Market Share And Leading Players
  • Fig. 45 Asia Pacific Market Share And Leading Players
  • Fig. 46 Latin America Market Share And Leading Players
  • Fig. 47 Middle East & Africa Market Share And Leading Players
  • Fig. 48 North America: SWOT
  • Fig. 49 Europe SWOT
  • Fig. 50 Asia Pacific SWOT
  • Fig. 51 Latin America SWOT
  • Fig. 52 MEA SWOT
  • Fig. 53 North America, By Country
  • Fig. 54 North America
  • Fig. 55 North America Market Estimates And Forecasts, 2018 - 2030
  • Fig. 56 U.S.
  • Fig. 57 U.S. Market Estimates And Forecasts, 2018 - 2030
  • Fig. 58 Canada
  • Fig. 59 Canada Market Estimates And Forecasts, 2018 - 2030
  • Fig. 60 Europe
  • Fig. 61 Europe Market Estimates And Forecasts, 2018 - 2030
  • Fig. 62 UK
  • Fig. 63 UK Market Estimates And Forecasts, 2018 - 2030
  • Fig. 64 Germany
  • Fig. 65 Germany Market Estimates And Forecasts, 2018 - 2030
  • Fig. 66 France
  • Fig. 67 France Market Estimates And Forecasts, 2018 - 2030
  • Fig. 68 Italy
  • Fig. 69 Italy Market Estimates And Forecasts, 2018 - 2030
  • Fig. 70 Spain
  • Fig. 71 Spain Market Estimates And Forecasts, 2018 - 2030
  • Fig. 72 Denmark
  • Fig. 73 Denmark Market Estimates And Forecasts, 2018 - 2030
  • Fig. 74 Sweden
  • Fig. 75 Sweden Market Estimates And Forecasts, 2018 - 2030
  • Fig. 76 Norway
  • Fig. 77 Norway Market Estimates And Forecasts, 2018 - 2030
  • Fig. 78 Asia Pacific
  • Fig. 79 Asia Pacific Market Estimates And Forecasts, 2018 - 2030
  • Fig. 80 China
  • Fig. 81 China Market Estimates And Forecasts, 2018 - 2030
  • Fig. 82 Japan
  • Fig. 83 Japan Market Estimates And Forecasts, 2018 - 2030
  • Fig. 84 India
  • Fig. 85 India Market Estimates And Forecasts, 2018 - 2030
  • Fig. 86 Thailand
  • Fig. 87 Thailand Market Estimates And Forecasts, 2018 - 2030
  • Fig. 88 South Korea
  • Fig. 89 South Korea Market Estimates And Forecasts, 2018 - 2030
  • Fig. 90 Australia
  • Fig. 91 Australia Market Estimates And Forecasts, 2018 - 2030
  • Fig. 92 Latin America
  • Fig. 93 Latin America Market Estimates And Forecasts, 2018 - 2030
  • Fig. 94 Brazil
  • Fig. 95 Brazil Market Estimates And Forecasts, 2018 - 2030
  • Fig. 96 Mexico
  • Fig. 97 Mexico Market Estimates And Forecasts, 2018 - 2030
  • Fig. 98 Argentina
  • Fig. 99 Argentina Market Estimates And Forecasts, 2018 - 2030
  • Fig. 100 Middle East And Africa
  • Fig. 101 Middle East And Africa Market Estimates And Forecasts, 2018 - 2030
  • Fig. 102 South Africa
  • Fig. 103 South Africa Market Estimates And Forecasts, 2018 - 2030
  • Fig. 104 Saudi Arabia
  • Fig. 105 Saudi Arabia Market Estimates And Forecasts, 2018 - 2030
  • Fig. 106 UAE
  • Fig. 107 UAE Market Estimates And Forecasts, 2018 - 2030
  • Fig. 108 Kuwait
  • Fig. 109 Kuwait Market Estimates And Forecasts, 2018 - 2030
  • Fig. 110 Market Share Of Key Market Players- Biomaterials Market